Noramco is a leading specialty active pharmaceutical ingredient (API) development and manufacturing company headquartered in Delaware. With operations worldwide, they specialize in controlled substance development and manufacturing, providing DEA-compliant security and production capacity for a range of therapeutic applications.
As a trusted partner to the pharmaceutical industry, Noramco offers high-purity controlled substances, including the Nal family of antagonists for addiction treatment and abuse prevention, as well as comprehensive ADHD technology solutions. With a global regulatory footprint and extensive experience, they are committed to advancing science and delivering solutions in the field of pharmaceutical development.
Generated from the website